Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
2(20%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_2
2
20%
Ph not_applicable
6
60%
Ph phase_4
2
20%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
2(20.0%)
Phase 4Post-market surveillance
2(20.0%)
N/ANon-phased studies
6(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(5)
Other(3)

Detailed Status

Completed5
unknown3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (20.0%)
Phase 42 (20.0%)
N/A6 (60.0%)

Trials by Status

completed550%
unknown330%
recruiting220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
RADIATION
Total Trials
10